Literature DB >> 22963370

Capturing the reaction pathway in near-atomic-resolution crystal structures of HIV-1 protease.

Chen-Hsiang Shen1, Yunfeng Tie, Xiaxia Yu, Yuan-Fang Wang, Andrey Y Kovalevsky, Robert W Harrison, Irene T Weber.   

Abstract

Snapshots of three consecutive steps in the proteolytic reaction of HIV-1 protease (PR) were obtained in crystal structures at resolutions of 1.2-1.4 Å. Structures of wild-type protease and two mutants (PR(V32I) and PR(I47V)) with V32I and I47V substitutions, which are common in drug resistance, reveal the gem-diol tetrahedral intermediate, the separating N- and C-terminal products, and the C-terminal product of an autoproteolytic peptide. These structures represent three stages in the reaction pathway and shed light on the reaction mechanism. The near-atomic-resolution geometric details include a short hydrogen bond between the intermediate and the outer carboxylate oxygen of one catalytic Asp25 that is conserved in all three structures. The two products in the complex with mutant PR(I47V) have a 2.2 Å separation of the amide and carboxyl carbon of the adjacent ends, suggesting partial cleavage prior to product release. The complex of mutant PR(V32I) with a single C-terminal product shows density for water molecules in the other half of the binding site, including a partial occupancy water molecule interacting with the product carboxylate end and the carbonyl oxygen of one conformation of Gly27, which suggests a potential role of Gly27 in recycling from the product complex to the ligand-free enzyme. These structural details at near-atomic resolution enhance our understanding of the reaction pathway and will assist in the design of mechanism-based inhibitors as antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963370      PMCID: PMC3476052          DOI: 10.1021/bi3008092

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

Review 1.  HIV-1 protease: mechanism and drug discovery.

Authors:  Ashraf Brik; Chi-Huey Wong
Journal:  Org Biomol Chem       Date:  2003-01-07       Impact factor: 3.876

Review 2.  2011 update of the drug resistance mutations in HIV-1.

Authors:  Victoria A Johnson; Vincent Calvez; Huldrych F Günthard; Roger Paredes; Deenan Pillay; Robert Shafer; Annemarie M Wensing; Douglas D Richman
Journal:  Top Antivir Med       Date:  2011-11

3.  Transition states of native and drug-resistant HIV-1 protease are the same.

Authors:  D Randal Kipp; Jennifer S Hirschi; Aya Wakata; Harris Goldstein; Vern L Schramm
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

Review 4.  Reaction intermediates discovered in crystal structures of enzymes.

Authors:  Irene T Weber; Johnson Agniswamy; Guoxing Fu; Chen-Hsiang Shen; Robert W Harrison
Journal:  Adv Protein Chem Struct Biol       Date:  2012       Impact factor: 3.507

5.  Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.

Authors:  Yunfeng Tie; Peter I Boross; Yuan-Fang Wang; Laquasha Gaddis; Fengling Liu; Xianfeng Chen; Jozsef Tozser; Robert W Harrison; Irene T Weber
Journal:  FEBS J       Date:  2005-10       Impact factor: 5.542

6.  SHELXL: high-resolution refinement.

Authors:  G M Sheldrick; T R Schneider
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

7.  Observation of a tetrahedral reaction intermediate in the HIV-1 protease-substrate complex.

Authors:  Mukesh Kumar; Vishal Prashar; Smita Mahale; Madhusoodan V Hosur
Journal:  Biochem J       Date:  2005-07-15       Impact factor: 3.857

8.  Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease following different protease inhibitor treatments.

Authors:  Thomas D Wu; Celia A Schiffer; Matthew J Gonzales; Jonathan Taylor; Rami Kantor; Sunwen Chou; Dennis Israelski; Andrew R Zolopa; W Jeffrey Fessel; Robert W Shafer
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  The HIV-1 protease as enzyme and substrate: mutagenesis of autolysis sites and generation of a stable mutant with retained kinetic properties.

Authors:  A M Mildner; D J Rothrock; J W Leone; C A Bannow; J M Lull; I M Reardon; J L Sarcich; W J Howe; C S Tomich; C W Smith
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

10.  HIV-1 Protease: Structural Perspectives on Drug Resistance.

Authors:  Irene T Weber; Johnson Agniswamy
Journal:  Viruses       Date:  2009-12-03       Impact factor: 5.048

View more
  4 in total

Review 1.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

2.  Joint X-ray/neutron crystallographic study of HIV-1 protease with clinical inhibitor amprenavir: insights for drug design.

Authors:  Irene T Weber; Mary Jo Waltman; Marat Mustyakimov; Matthew P Blakeley; David A Keen; Arun K Ghosh; Paul Langan; Andrey Y Kovalevsky
Journal:  J Med Chem       Date:  2013-06-28       Impact factor: 7.446

3.  Highly Drug-Resistant HIV-1 Protease Mutant PRS17 Shows Enhanced Binding to Substrate Analogues.

Authors:  Johnson Agniswamy; Daniel W Kneller; Rowan Brothers; Yuan-Fang Wang; Robert W Harrison; Irene T Weber
Journal:  ACS Omega       Date:  2019-05-17

4.  Visualizing Tetrahedral Oxyanion Bound in HIV-1 Protease Using Neutrons: Implications for the Catalytic Mechanism and Drug Design.

Authors:  Mukesh Kumar; Kalyaneswar Mandal; Matthew P Blakeley; Troy Wymore; Stephen B H Kent; John M Louis; Amit Das; Andrey Kovalevsky
Journal:  ACS Omega       Date:  2020-05-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.